35.10.02 · health-medicine / surgery-emergency-medicine

Cardiopulmonary bypass and the heart-lung machine: Gibbon's decades-long quest, Bigelow's hypothermia, and the open-heart-surgery revolution

shipped3 tiersLean: none

Anchor (Master): primary sources: Le Gallois 1812; von Schröder 1882; Gibbon 1937+1953; Bigelow 1950; Lillehei 1955; DeWall 1955; Kirklin 1955

Intuition Beginner

Before 1953, the heart was the one organ surgeons could not open directly. The beating heart pushes blood through the body every second of life. If a surgeon stopped it to cut into its walls, the brain died within minutes from lack of oxygenated blood. So for half a century, heart surgery meant working fast on a moving target, repairing only what could be reached from the outside.

The solution was to build a machine that temporarily does both jobs at once: pump the blood and add oxygen to it. This heart-lung machine drains blood from the body's large veins, pushes it through an oxygenator that swaps carbon dioxide for oxygen, warms or cools the flow as needed, and returns it to the body's main artery. With the machine running, the surgeon can stop the heart, open a chamber, repair a hole or a damaged valve, then restart it.

John Gibbon, a surgeon in Philadelphia, chased this idea for 23 years. He built prototype after prototype, first keeping cats and dogs alive on the machine, then slowly scaling up to humans. On May 6, 1953, he used his device on 18-year-old Cecilia Bavolek, closed a birth-defect hole between her heart's upper chambers, and she lived another 47 years. About 500,000 open-heart operations are now performed each year worldwide.

Visual Beginner

The circuit has seven parts in sequence. Two thin tubes called cannulas are sewn into the patient: one drains blood from the right side of the heart, the other returns warmed, oxygenated blood to the body's main artery. Between them the blood passes through a reservoir bag, a pump, an oxygenator that exchanges gas across a membrane, a heat exchanger that warms or cools the flow, and a filter that catches any stray particles.

Cooling the blood cools the whole patient. At 28 degrees Celsius the body's cells need only about half their usual oxygen, which gives the surgeon more time to work before any tissue is harmed. Combined with a drug that stops the heart still, this lets repairs take an hour or more without brain injury.

Worked example Beginner

The patient. Cecilia Bavolek, 18 years old, was born with an atrial septal defect — a hole between the left and right atria, the two upper chambers of her heart. Some of the oxygen-rich blood returning from her lungs leaked back through the hole into the lungs instead of flowing out to the body. Without surgery she faced progressive heart and lung damage through her twenties and thirties.

May 6, 1953, Jefferson Medical College Hospital, Philadelphia. Gibbon connected Cecilia to his heart-lung machine. For 26 minutes the machine pumped and oxygenated her blood while her heart was stopped and opened. He closed the hole with sutures, restarted the heart, withdrew the cannulas, and she regained consciousness with the defect repaired. She recovered fully and died in 2000 at age 65, having lived 47 years after the operation that founded modern cardiac surgery.

Step 1: the machine replaced the work of the heart and the lungs for the 26 minutes needed to stop, open, repair, and restart the heart.

Step 2: oxygenated blood continued to reach the brain throughout, so no brain injury occurred despite the heart being motionless and bloodless.

What this tells us: a single successful human case, after 23 years of laboratory development, proved the principle and opened the era of open-heart surgery. Gibbon's next three operations failed; he was devastated and never operated again, but his device, refined by Lillehei and Kirklin within two years, became routine.

Check your understanding Beginner

Exercise 4 (easy, multiple choice).

What is the function of the oxygenator component of the heart-lung machine?

A. It cools the blood to below freezing B. It produces red blood cells C. It adds oxygen to the blood and removes carbon dioxide, doing the lung's job D. It filters cholesterol out of the blood

Hint

The name matches the organ it replaces. The pump replaces the heart; the oxygenator replaces what the lungs do.

Answer

Option C. The oxygenator performs the gas-exchange work of the lungs: oxygen diffuses into the blood across a membrane (or bubbles through it in older designs) and carbon dioxide diffuses out. Modern clinical oxygenators use semipermeable membranes that mimic the alveolar-capillary barrier; cooling is handled by a separate heat exchanger, and red-cell production is the job of bone marrow.

Formal definition Intermediate+

Definition (cardiopulmonary bypass). Cardiopulmonary bypass (CPB) is the extracorporeal mechanical support of the systemic circulation in which venous blood is drained from the great veins, pumped through an artificial gas-exchange device, temperature-conditioned, and returned to the arterial tree, thereby replacing the pumping function of the heart and the gas-exchange function of the lungs for a controlled interval. The patient undergoing CPB is systemically heparinized to prevent clotting within the artificial circuit, and the heart is usually arrested by cardioplegia to provide a still, bloodless surgical field.

Definition (the CPB circuit). A standard adult CPB circuit consists of seven serial components:

Venous cannula — placed in the right atrium or superior and inferior venae cavae, draining venous blood by gravity siphon at near-zero pressure.
Venous reservoir — a collapsible cardiotomy bag that buffers flow mismatches and traps air.
Pump — most commonly a roller pump (occlusive, two rollers compressing a length of tubing in a raceway), producing near-physiologic, minimally pulsatile flow at 2 to 5 L/min in an adult; alternatively a centrifugal pump (constrained vortex), which causes less haemolysis and is preferred for prolonged runs.
Oxygenator — the modern membrane oxygenator, a hollow-fibre or flat-sheet device in which gas exchange occurs across a semipermeable polypropylene or polymethylpentene membrane that separates blood from the oxygen-rich sweep-gas compartment. Earlier film oxygenators (Gibbon 1953) spread blood as a thin film in an oxygen atmosphere; bubble oxygenators (DeWall 1955) bubbled oxygen directly through blood, which was simpler and cheaper but caused more haemolysis and complement activation. Membrane designs have been standard since the 1980s.
Heat exchanger — a counter-current stainless-steel or polymeric device that warms or cools the blood to set systemic temperature; cooling to 28 to 32 degrees Celsius produces moderate hypothermia, and cooling to 18 degrees produces deep hypothermia, permitting total circulatory arrest for 30 to 45 minutes in aortic-arch surgery.
Arterial filter — a 20 to 40 micron screen that catches particulate and gaseous emboli before they reach the aorta.
Arterial cannula — placed in the ascending aorta, returning oxygenated blood at pressures approximating native systemic pressure.

Definition (systemic heparinization and protamine reversal). Before cannulation the patient receives an intravenous bolus of unfractionated heparin, typically 300 to 400 units per kilogram, to achieve an activated clotting time (ACT) above 480 seconds. Heparin potentiates antithrombin III, which inhibits thrombin and factor Xa and prevents clot formation on the artificial surfaces of the circuit. At the conclusion of CPB, heparin is reversed with protamine sulfate, a polycationic peptide that binds heparin stoichiometrically (about 1 mg of protamine neutralizes 100 units of heparin), restoring normal coagulation. Heparin-induced thrombocytopenia (HIT), an IgG-mediated platelet-activation syndrome occurring 5 to 14 days after exposure, is the principal immunologic complication and mandates alternative anticoagulation (bivalirudin, argatroban).

Definition (cardioplegia). Cardioplegia is the intentional induction of cardiac arrest for surgical purposes. The standard solution is a cold (4 to 10 degrees Celsius), hyperkalemic (10 to 30 mmol/L potassium) crystalloid or blood-based solution infused into the coronary circulation either antegradely through the aortic root or retrogradely through the coronary sinus. The elevated extracellular potassium depolarises the cardiomyocyte membrane, inactivating fast sodium channels and abolishing the action potential; the heart arrests in diastole. Hypothermia further reduces metabolic demand, and the combination typically yields a safe arrest time of 60 to 120 minutes before ischaemic injury becomes problematic.

Definition (hypothermia on CPB). Moderate hypothermia (28 to 32 degrees Celsius) is used for routine coronary and valve surgery; deep hypothermia (18 degrees Celsius) with total circulatory arrest is reserved for aortic-arch and complex congenital surgery. The empirical rule of thumb, due to Bigelow 1950, is that cerebral metabolic rate for oxygen falls by roughly 6 to 7 percent per degree Celsius cooling; at 18 degrees the cerebral metabolic rate is approximately 15 to 20 percent of normothermic baseline, extending the tolerable arrest time from about 3 to 5 minutes at normothermia to 30 to 45 minutes at deep hypothermia.

Counterexamples to common slips Intermediate+

"The heart must keep beating during CPB." No. The defining feature of CPB for intracardiac surgery is that the heart is arrested by cardioplegia, producing a still, bloodless field. The body is perfused by the machine. Beating-heart (off-pump) CABG deliberately avoids CPB and the arrested-heart technique.
"CPB is safe and routine, so complications are negligible." CPB is routine (over one million adult cases per year worldwide) but carries measurable risks: stroke 1 to 5 percent, acute kidney injury around 5 percent, and a systemic inflammatory response in essentially every patient to some degree.
"Bigelow's hypothermia approach was rejected." No. Bigelow's 1950 demonstration that hypothermia prolongs the tolerable circulatory-arrest time is now standard practice, combined with CPB for nearly all cardiac operations and used alone or with CPB for arch surgery.
"ECMO is the same as a heart-lung machine." The technology is closely related (pump plus membrane oxygenator), but ECMO is for prolonged support of a failing heart or lungs in an intensive-care setting — days to weeks — whereas CPB for surgery is short-term (typically one to four hours) and includes a reservoir open to air.
"Off-pump CABG is always better than on-pump." Contested. Randomized trials (ROOBY, CORONARY) show no clear long-term survival advantage and slightly lower graft-patency with off-pump, at the cost of greater technical difficulty.
"TAVR eliminates the need for CPB." Only for selected aortic-valve patients. Most coronary bypass, multivalve, congenital, and transplant surgery still requires CPB.

Key mechanism: the CPB circuit and cardioplegia Intermediate+

The mechanism by which CPB permits open-heart repair has five coupled sub-mechanisms: (1) the circuit diverts venous return to an external pump, restoring flow to the systemic arteries at near-physiologic pressure and flow rate; (2) the oxygenator exchanges oxygen and carbon dioxide across a membrane at rates matching whole-body metabolic demand; (3) systemic heparinization prevents clotting in the artificial circuit without eliminating the patient's clotting factors; (4) cardioplegia arrests the heart in diastole, producing a still, bloodless surgical field and reducing myocardial oxygen demand by 80 to 90 percent; and (5) hypothermia reduces systemic metabolic rate, lengthening the safe ischaemic window for both the brain and the arrested heart.

Key theorem: the hypothermic safe-arrest window

Theorem (hypothermia extends safe circulatory arrest, Bigelow 1950). Let $T$ be the patient's core temperature in degrees Celsius and let $CMRO_{2} (T)$ denote the cerebral metabolic rate for oxygen. Empirically, $CMRO_{2}$ satisfies the van 't Hoff-Arrhenius-style relation $CMRO_{2} (T) \approx CMRO_{2} (37) \cdot Q_{10}^{(T - 37) /10}$ with $Q_{10} \approx 2.0$ to $2.5$ for cerebral tissue in this temperature range, so cooling from 37 to 18 degrees reduces cerebral oxygen demand to roughly $Q_{10}^{- 1.9} \approx 0.20$ of normothermic baseline. The corresponding tolerable duration of total circulatory arrest scales approximately inversely with metabolic rate, rising from about 3 to 5 minutes at normothermia to about 30 to 45 minutes at 18 degrees.

Proof. Define $τ (T)$ as the maximum ischaemic interval after which neurologic injury is detected in 50 percent of subjects. The cellular ATP deficit accumulated over ischaemic interval $t$ at temperature $T$ is approximately

Δ ATP (t, T) = CMRO_{2} (T) \cdot t - ATP_{buffer},

where $ATP_{buffer}$ is the total ATP regenerable from phosphocreatine and anaerobic glycolysis before irreversible injury. Neurologic injury occurs at a critical deficit $Δ ATP_{crit}$ , so

τ (T) = \frac{Δ ATP _{crit} + ATP _{buffer}}{CMRO _{2} ( T )} \propto Q_{10}^{(37 - T) /10} .

Plugging in $Q_{10} = 2.5$ gives $τ (28) / τ (37) = 2. 5^{0.9} \approx 2.3$ and $τ (18) / τ (37) = 2. 5^{1.9} \approx 5.7$ , consistent with Bigelow's 1950 feline experiments and the modern clinical anchor of 30 to 45 minutes of safe arrest at 18 degrees. $□$

Bridge. This result builds toward the deep-hypothermic circulatory arrest used in aortic-arch reconstruction in 35.10.01 and appears again in modern ECMO practice, where induced hypothermia after cardiac arrest protects the brain; the foundational reason is that metabolic demand scales as a van 't Hoff function of temperature, and this is exactly the bridge between Bigelow's 1950 laboratory observation and the contemporary targeted-temperature-management protocols that identify cooling with neuroprotection across cardiac surgery, transplant preservation, and post-arrest care.

The systemic inflammatory response and reperfusion injury

Blood contact with the artificial surfaces of the CPB circuit activates complement (C3a, C5a), leukocytes, monocytes, platelets, and the contact-activation (intrinsic) coagulation cascade. Cytokines including interleukin-6, interleukin-8, and tumour necrosis factor-alpha are released, producing a systemic inflammatory response syndrome (SIRS) proportional to the duration of CPB. Clinically this manifests as a capillary-leak syndrome (interstitial oedema, 5 to 10 percent weight gain over 24 hours), transient pulmonary dysfunction, and in susceptible patients multi-organ dysfunction. Reperfusion injury occurs when the heart or other ischaemic organs are re-perfused at the conclusion of arrest: a burst of reactive oxygen species, intracellular calcium overload, and mitochondrial permeability-transition opening cause additional cell injury beyond that produced by ischaemia itself.

Exercises Intermediate+

Exercise 3 (medium, multiple choice).

A 70 kg patient receives 25,000 units of unfractionated heparin for CPB. At the conclusion of bypass, the perfusionist will give protamine to reverse anticoagulation. Using the standard ratio of 1 mg protamine per 100 units of heparin, what total protamine dose is most appropriate?

A. 25 mg B. 250 mg C. 2,500 mg D. 25,000 mg

Hint

Divide the heparin dose in units by 100 to get the milligram dose of protamine that binds the heparin stoichiometrically.

Answer

Option B. $25, 000/100 = 250$ mg of protamine sulfate given slowly intravenously (over 5 to 10 minutes, since rapid infusion can cause hypotension, pulmonary vasoconstriction, and rarely catastrophic protamine-heparin anaphylaxis). The activated clotting time is rechecked after the dose to confirm return to baseline; over- or under-dosing is detected and corrected by incremental 25 to 50 mg protamine boluses.

Exercise 5 (medium, multiple choice).

Why does the modern membrane oxygenator cause less haemolysis and complement activation than the older DeWall-Lillehei bubble oxygenator?

A. It uses pure oxygen; the bubble oxygenator used room air B. It separates blood and gas by a semipermeable membrane, eliminating the direct blood-gas interface C. It uses larger oxygen bubbles that do not damage red cells D. It is cooled to 4 degrees Celsius, which stabilises red cell membranes

Hint

Direct contact between a turbulent blood-gas interface and the protein-rich plasma is the principal insult; eliminating that interface removes the dominant source of damage.

Answer

Option B. In a bubble oxygenator, oxygen is bubbled directly through blood, creating a turbulent blood-gas interface that denatures plasma proteins, shears red cells, and activates complement and leukocytes. In a membrane oxygenator, blood and gas flow on opposite sides of a semipermeable membrane; gas diffuses across without any blood-gas interface, dramatically reducing haemolysis and protein denaturation. Membrane oxygenators displaced bubble designs in the 1980s for this reason.

Exercise 6 (medium, multiple choice).

Which of the following best explains why cardioplegia arrests the heart in diastole rather than systole?

A. The cardioplegia solution contains calcium, which drives the heart into sustained contraction B. The hyperkalemic cardioplegia depolarises the cardiomyocyte membrane, inactivating fast sodium channels and abolishing the action potential; the heart stops in the resting (diastolic) configuration C. Cold temperature directly paralyzes the contractile apparatus in diastole D. The heart cannot be arrested in systole for physical reasons independent of the cardioplegia composition

Hint

Cardioplegia achieves arrest by raising extracellular potassium, which keeps the membrane depolarised past the inactivation threshold of the fast sodium channel.

Answer

Option B. Raising extracellular potassium to 10 to 30 mmol/L shifts the resting membrane potential from approximately $- 90$ mV toward $- 60$ mV, at which the fast sodium channels are inactivated and no action potential can be generated. The myocardium settles into its resting state, which for cardiac muscle is diastole. This produces a still, relaxed, bloodless field, which is the surgical goal.

Exercise 7 (hard, numeric).

A 60 kg patient is cooled to 18 degrees Celsius for aortic-arch reconstruction under deep hypothermic circulatory arrest. Using the model $τ (T) \propto Q_{10}^{(37 - T) /10}$ with $Q_{10} = 2.5$ and a normothermic cerebral safe-arrest time of 4 minutes, compute the approximate safe-arrest time at 18 degrees, then identify which of the following clinical limits is closest: 15 min, 30 min, 60 min, or 120 min.

Hint

$τ (18) = 4 \cdot 2. 5^{1.9}$ . Compute $2. 5^{1.9} \approx 5.7$ .

Answer

Approximately 23 minutes, closest clinical limit 30 min. $τ (18) = 4 \cdot 2. 5^{1.9} \approx 4 \cdot 5.7 \approx 22.8$ minutes. Clinical practice extends this to 30 to 45 minutes by adjunctive measures (cerebral perfusion, ice packs to the head, gradual rather than abrupt cooling) and by individual patient variability. Beyond 45 minutes the incidence of permanent neurologic injury rises sharply; this is the limiting factor in aortic-arch surgery.

Exercise 8 (hard, multiple choice).

Gibbon performed only one fully successful clinical CPB operation (the 1953 Bavolek case); his subsequent three operations all failed, and he withdrew from cardiac surgery. Within two years, Lillehei's group at Minnesota and Kirklin's group at Mayo reported reproducible series. Which historical factor most accounts for the rapid transition from a single isolated success in 1953 to routine clinical use by 1955 to 1956?

A. Gibbon's machine was technologically superior and required no improvement B. Lillehei's controlled cross-circulation (1954) and DeWall-Lillehei helix-reservoir bubble oxygenator (1955) provided simpler, more reliable alternatives to Gibbon's complex film oxygenator, and Kirklin's Mayo series (1955) proved reproducibility with a Gibbon-type machine built by IBM engineers C. Cardiac surgery was illegal before 1954 and the regulatory environment then changed D. Antibiotics and heparin were not available before 1954

Hint

Consider what made the technology reproducible across centers: simpler hardware, an alternative bridging technology, and a published multi-patient series.

Answer

Option B. Three factors converged in 1954 to 1955: (i) Lillehei's controlled cross-circulation, in which a parent's circulation oxygenated the child's blood during repair, bypassed the need for a fully engineered oxygenator and produced a successful series of 45 operations (1954 to 1955) despite the substantial risk to the parent; (ii) the DeWall-Lillehei helix-reservoir bubble oxygenator, which was cheap, disposable, and required no film apparatus; and (iii) Kirklin's eight-patient Mayo Clinic series (1955) using a redesigned Gibbon-type machine built by IBM, which proved the technology was reproducible across centers. Heparin had been available since the 1930s and antibiotics were well established by 1953; no regulatory barrier existed.

Exercise 9 (hard, multiple choice).

Compared with on-pump coronary artery bypass grafting (CABG), which statement best summarizes the evidence on off-pump CABG (beating-heart surgery) from the major randomized trials (ROOBY, CORONARY, GOPCABE)?

A. Off-pump CABG has a clear long-term survival advantage over on-pump B. Off-pump CABG eliminates all stroke risk and is therefore preferred for all patients C. Off-pump avoids CPB-related inflammatory and embolic exposure, but at five-year follow-up shows no clear survival advantage and slightly lower complete revascularization and graft-patency rates; choice depends on anatomy and surgeon expertise D. Off-pump CABG is contraindicated in all patients with multivessel disease

Hint

Avoiding CPB removes the inflammatory and embolic exposure but makes the distal anastomoses technically harder, which affects graft quality and completeness of revascularization.

Answer

Option C. The three major trials (ROOBY 2009 and 2017, CORONARY 2012 and 2017, GOPCABE 2013) consistently show that off-pump CABG reduces transfusion, ventilation time, and some early complications, but at five-year follow-up shows no overall survival advantage and slightly worse graft-patency and completeness of revascularization. A subset of patients with severe aortic atherosclerosis (where aortic manipulation is the main stroke risk) may benefit from off-pump, but it is not preferred for all patients.

Advanced results Master

Result 1 (Le Gallois 1812 — the theoretical prediction). The French physiologist Julien Jean César Le Gallois first proposed that life could be sustained by an artificial replacement of the heart's pumping function, observing that a portion of the body might be kept alive if the equivalent of the heart's action were supplied to it ^{[LeGallois1812]}. Le Gallois did not build such a device; his contribution is the conceptual assertion that the heart is a pump and that pumping is, in principle, replaceable. Every CPB machine built since 1953 is an engineering answer to Le Gallois's 1812 question.

Result 2 (von Schröder 1882 — the first bubble oxygenator). von Schröder constructed the first device in which oxygen was bubbled through blood to oxygenate it, anticipating the DeWall-Lillehei design by 73 years ^{[VonSchroder1882]}. The principle — direct blood-gas contact for rapid oxygen transfer — remained the basis of the cheaper oxygenator designs through the 1970s, until membrane designs displaced bubble oxygenators on grounds of haemolysis and complement activation.

Result 3 (Bigelow-Lindsay-Greenwood 1950 — hypothermia for cardiac surgery). Working at the Banting Institute in Toronto, Bigelow demonstrated that cooling dogs to 20 degrees Celsius prolonged the tolerable period of inflow occlusion from about 3 minutes to about 15 minutes, with full neurologic recovery on rewarming ^{[Bigelow1950]}. The empirical observation that cerebral metabolic rate falls roughly 6 to 7 percent per degree Celsius of cooling (the quantitative form of the Key theorem above) became the load-bearing fact for deep hypothermic circulatory arrest in aortic-arch surgery and the conceptual basis for modern targeted temperature management after cardiac arrest.

Result 4 (Gibbon 1937 to 1953 — the heart-lung machine). Gibbon's 1937 paper in Archives of Surgery demonstrated that cats could survive experimental occlusion of the pulmonary artery when supported by his experimental apparatus, the first sustained vertebrate life on an artificial cardiopulmonary support ^[Gibbon1937]. Sixteen years of engineering followed, supported through the 1940s and early 1950s by the IBM Corporation under Thomas Watson Sr., culminating in the May 6, 1953 operation on Cecilia Bavolek ^[Gibbon1954]. The Gibbon-IBM machine used a vertical film oxygenator (blood spread as a thin film over rotating cylinders in an oxygen atmosphere), roller pumps, and a separate cardiotomy return line.

Result 5 (Lillehei-Cohen-Warden-Varco 1955 — controlled cross-circulation). Lillehei's group at the University of Minnesota, frustrated by the complexity of contemporary oxygenators, used a parent's circulation as the oxygenator for a child undergoing intracardiac repair: the child's venous blood was diverted to the parent, oxygenated by the parent's lungs, and returned to the child's arterial system ^{[Lillehei1955]}. Between March 1954 and July 1955, 45 children underwent repair of ventricular septal defect, tetralogy of Fallot, and atrioventricular canal defects. Although the risk to the parent was substantial and one parent died, the series established that intracardiac repair of complex congenital defects was feasible and reproducible, and provided the clinical bridge until the DeWall-Lillehei bubble oxygenator was ready later in 1955.

Result 6 (DeWall-Lillehei 1955 — the helix-reservoir bubble oxygenator). The DeWall-Lillehei helix-reservoir bubble oxygenator, reported in late 1955, used a length of plastic tubing coiled into a vertical helix in which oxygen bubbled through venous blood and then debubbled through a settling chamber ^[DeWall1955]. It was inexpensive, disposable, and assembled from off-the-shelf components, and it rapidly displaced the complex Gibbon-IBM film apparatus. The bubble oxygenator dominated clinical CPB for the next 25 years until the membrane oxygenator became standard in the 1980s.

Result 7 (Kirklin-Dushane 1955 — reproducibility at Mayo). Kirklin's group at the Mayo Clinic reported an eight-patient series in 1955 using a redesigned Gibbon-type machine (the Mayo-Gibbon apparatus, engineered by IBM), demonstrating that the 1953 Bavolek result was reproducible at a second center with a different surgical team ^{[Kirklin1955]}. This was the result that converted Gibbon's isolated success into an established surgical specialty: by 1957 more than a dozen centers had operative CPB programmes.

Result 8 (the systemic inflammatory response and modern variants). Modern clinical refinements include off-pump CABG (avoiding CPB), veno-arterial and veno-venous ECMO (prolonged support of failing heart or lungs in the intensive-care setting, widely deployed in the COVID-19 pandemic), transcatheter aortic valve replacement (TAVR, which avoids CPB for selected elderly patients), and mechanical circulatory support with left-ventricular assist devices (LVADs, used as bridge-to-transplant or destination therapy). The cellular substrate of CPB complications — complement activation (C3a, C5a), leukocyte activation, cytokine release, capillary leak, and the reperfusion injury that occurs at the end of cardioplegic arrest — was characterized in the 1980s and 1990s by Kirklin, Chenoweth, and others, and remains the principal unsolved problem of open-heart surgery.

Synthesis. The 23-year arc from Gibbon's 1930 elevator encounter with a dying patient to the May 6, 1953 Bavolek operation is the foundational reason that cardiac surgery exists as a discipline at all. The central insight — that venous blood can be drained, pumped, oxygenated, and returned without the heart or lungs, while a still, bloodless field is achieved by cardioplegia — builds toward the modern CPB circuit and appears again in ECMO, where the same pump-oxygenator technology is repurposed for prolonged intensive-care support. The bridge is between Bigelow's 1950 hypothermia and the contemporary targeted-temperature-management protocols used after cardiac arrest, and this is exactly the structure that identifies reversible circulatory arrest with controlled cerebral metabolism. Putting these together with the DeWall bubble oxygenator and the Kirklin reproducibility series, the pattern generalises across every subsequent mechanical-circulatory-support technology, from centrifugal pumps and LVADs to total artificial hearts and ex-vivo perfused organ preservation.

Full proof set Master

Proposition 1 (Gibbon's 1953 case proves CPB viability). If a single mammal can be sustained on a mechanical pump-oxygenator for the duration required to stop, open, repair, and restart the heart, with full neurologic and hemodynamic recovery, then CPB is in principle a viable clinical technique.

Proof. Define a successful CPB operation as one in which (i) the patient is weaned from the machine with native cardiac output restored, (ii) the patient survives the operation, and (iii) the patient recovers with no new neurologic deficit attributable to inadequate perfusion during the support interval. The May 6, 1953 Bavolek operation satisfies all three conditions: 26 minutes on CPB with the heart arrested and opened, surgical closure of the atrial septal defect, full postoperative recovery, and 47 years of subsequent survival. Therefore CPB is viable as a clinical technique. Subsequent failures (Gibbon's three later operations) reflect engineering limitations of the 1953 film oxygenator and the learning curve of the surgical team, not a flaw in the principle; the principle was established by the single successful case. $□$

Proposition 2 (hypothermia multiplicatively extends the safe-arrest window). Under the model $τ (T) \propto Q_{10}^{(37 - T) /10}$ , moderate hypothermia (32 degrees Celsius) extends the safe-arrest window by approximately 60 to 80 percent over normothermia, and deep hypothermia (18 degrees Celsius) extends it by a factor of 5 to 6.

Proof. Setting $Q_{10} = 2.5$ and the normothermic reference $τ (37) = 4$ minutes: $τ (32) = 4 \cdot 2. 5^{0.5} \approx 4 \cdot 1.58 \approx 6.3$ minutes (a 58 percent extension). $τ (18) = 4 \cdot 2. 5^{1.9} \approx 22.8$ minutes (a factor of about 5.7). These figures match Bigelow's 1950 canine data and the modern clinical anchors of 5 to 7 minutes at moderate hypothermia, 30 to 45 minutes at deep hypothermia. The multiplicative form explains why deep hypothermia with total circulatory arrest — rather than moderate hypothermia with low-flow CPB — became the standard for aortic-arch reconstruction: the safe interval scales as a power of the temperature reduction, not a linear function. $□$

Proposition 3 (the systemic inflammatory response is unavoidable but bounded). Any extracorporeal circuit of non-endothelial surface in contact with whole blood activates complement and leukocytes; the magnitude of the resulting SIRS scales approximately with the duration of CPB and the total artificial surface area.

Proof. Complement activation begins within 60 seconds of blood exposure to the artificial surfaces, as demonstrated by measurement of C3a and C5a levels in the venous line: these anaphylatoxins rise monotonically throughout the bypass run. The downstream cascade — leukocyte margination, cytokine release (interleukin-6 peaking at 4 to 6 hours postoperatively), capillary leak (5 to 10 percent body-weight gain over 24 hours), and transient pulmonary and renal dysfunction — is observed in essentially every patient to some degree, confirming that SIRS is intrinsic to CPB rather than an idiosyncratic reaction. The magnitude is bounded by circuit duration (most reactions resolve within 24 to 48 hours for runs under 4 hours) and is mitigated by surface-coated circuits (heparin-bonded, phosphorylcholine-coated), reduced prime volume, and biocompatible pump design. Off-pump surgery avoids the cascade entirely at the cost of technical difficulty, which is the central trade-off in modern coronary surgery. $□$

Connections Master

Surgery and emergency medicine survey 35.10.01. This unit is the depth slice for one of the canonical breakthroughs named in the chapter survey; the survey's overview of surgical principles, sterile technique, anaesthesia, and the historical arc from Lister to modern operating-room practice frames the present unit, and the cross-reference identifies Gibbon's 1953 operation as the inflection point at which cardiac surgery became feasible. The survey's account of controlled hypotension, fluid management, and the physiologic monitoring of the surgical patient generalises to the perfusionist's management of CPB flows, pressures, and temperatures.
Cardiovascular physiology 18.02.01. This peer established the Frank-Starling mechanism, the cardiac cycle, the determinants of cardiac output (heart rate, preload, afterload, contractility), and the pulmonary and systemic circulations. The CPB circuit is engineered to reproduce the physiologic outputs of exactly the organs described there: a flow of 4 to 6 L/min at near-physiologic pressure (the cardiac output target), a membrane that performs alveolar gas exchange, and cannulation strategies that respect the atrial and great-vessel anatomy the physiology unit establishes. Without the physiologic foundation in 18.02.01, the design constraints on the CPB circuit are unmotivated.
Chronic disease survey 35.03.01. Coronary artery disease, valvular heart disease, and heart failure are the leading chronic diseases whose surgical treatment depends on CPB: coronary artery bypass grafting (the most common adult cardiac operation), valve repair and replacement (aortic, mitral, tricuspid), and surgical ventricular restoration or transplantation. The chronic-disease survey's framing of cardiovascular disease as the leading global cause of death identifies CPB as one of the highest-impact interventions in modern medicine, with over one million adult cardiac operations performed worldwide each year, the vast majority under CPB.
Cytochrome P450 pharmacogenomics 35.07.04. Anaesthetic and analgesic agents used during cardiac surgery (fentanyl, propofol, midazolam, volatile anaesthetics) are metabolised by CYP3A4 and CYP2D6, the polymorphic enzymes characterised in this peer; pharmacogenomic variation accounts for substantial interpatient variability in anaesthetic depth, postoperative opioid requirement, and the risk of prolonged sedation after long CPB runs. The CYP-mediated metabolism of warfarin (CYP2C9 and VKORC1) also governs the postoperative anticoagulation that follows the heparin-protamine reversal at the end of CPB, identifying pharmacogenomics as the bridge between intraoperative anticoagulation and long-term postoperative management.

Historical & philosophical context Master

The conceptual assertion that the heart's function could be replaced by a machine is due to the French physiologist Le Gallois, who wrote in 1812 that the heart is in essence a pump and that any part of the body might be kept alive by an equivalent mechanical action ^{[LeGallois1812]}. The first engineering instantiation, von Schröder's 1882 bubble oxygenator, demonstrated the principle of direct blood-gas contact oxygenation ^{[VonSchroder1882]}; the modern quantitative foundation for hypothermic arrest is due to Bigelow, Lindsay, and Greenwood at the Banting Institute in Toronto, whose 1950 Annals of Surgery paper showed that cooled dogs tolerated prolonged inflow occlusion with full recovery ^{[Bigelow1950]}.

Gibbon's 1937 Archives of Surgery paper reported the first sustained vertebrate life on an artificial pump-oxygenator ^[Gibbon1937], and the May 6, 1953 operation on Cecilia Bavolek at Jefferson Medical College Hospital — reported in Minnesota Medicine in 1954 ^[Gibbon1954] — was the first fully successful clinical open-heart operation. Gibbon performed only three further operations, all fatal, and withdrew from cardiac surgery; his withdrawal was not a refutation of the technique but a recognition that the 1953 film oxygenator had reached its engineering limit. Within two years, Lillehei's controlled cross-circulation series ^{[Lillehei1955]} and the DeWall-Lillehei helix-reservoir bubble oxygenator ^[DeWall1955] provided simpler, cheaper, disposable alternatives, and Kirklin's eight-patient Mayo Clinic series ^{[Kirklin1955]} demonstrated reproducibility at a second center using a redesigned Gibbon-type machine engineered by IBM.

The downstream consequences transformed cardiac surgery from a laboratory endeavor into a clinical specialty: the Starr-Edwards caged-ball valve (1960) was the first successful prosthetic heart valve and depended on CPB for implantation; the first human heart transplant by Barnard in Cape Town on December 3, 1967, and the first US transplant by Cooley in May 1968, depended on the CPB techniques established in the prior decade. The technology continues to evolve: off-pump CABG avoids the bypass circuit entirely for selected coronary patients; ECMO provides prolonged cardiopulmonary support in the intensive-care setting and was widely deployed in the COVID-19 pandemic; TAVR obviates CPB for selected elderly aortic-valve patients; and LVADs provide destination therapy or bridge-to-transplant for end-stage heart failure. The mechanistic basis — pump flow, membrane gas exchange, anticoagulation balance, cardioplegic arrest, and hypothermic neuroprotection — was fixed by 1955.

Bibliography Master

@book{LeGallois1812,
  author    = {Le Gallois, Julien Jean C\'esar},
  title     = {Expositions du syst\`eme de la respiration},
  publisher = {Gabon},
  address   = {Paris},
  year      = {1812},
}

@article{VonSchroder1882,
  author  = {von Schr{\"o}der, W.},
  title   = {{\"U}ber die Bildungsst{\"a}tte der Galls{\"a}ure},
  journal = {Archiv f\"ur experimentelle Pathologie und Pharmakologie},
  volume  = {14},
  pages   = {63--88},
  year    = {1882},
}

@article{Gibbon1937,
  author  = {Gibbon, J. H.},
  title   = {Artificial maintenance of circulation during experimental
             occlusion of pulmonary artery},
  journal = {Archives of Surgery},
  volume  = {34},
  number  = {6},
  pages   = {1105--1113},
  year    = {1937},
  doi     = {10.1001/archsurg.1937.01150120025002},
}

@article{Bigelow1950,
  author  = {Bigelow, W. G. and Lindsay, W. K. and Greenwood, W. F.},
  title   = {Hypothermia; its possible role in cardiac surgery:
             investigation of factors governing survival in dogs
             at low body temperatures},
  journal = {Annals of Surgery},
  volume  = {132},
  number  = {5},
  pages   = {849--866},
  year    = {1950},
  doi     = {10.1097/00000658-195011000-00006},
}

@article{Gibbon1954,
  author  = {Gibbon, J. H.},
  title   = {Application of a mechanical heart and lung apparatus
             to cardiac surgery},
  journal = {Minnesota Medicine},
  volume  = {37},
  pages   = {171--185},
  year    = {1954},
}

@article{Lillehei1955,
  author  = {Lillehei, C. W. and Cohen, M. and Warden, H. E. and
             Varco, R. L.},
  title   = {The direct-vision intracardiac correction of
             congenital anomalies by controlled cross circulation:
             results in thirty-two patients with ventricular septal
             defects, tetralogy of {F}allot, and atrioventricular
             canal defects},
  journal = {Surgery},
  volume  = {38},
  number  = {1},
  pages   = {11--29},
  year    = {1955},
}

@article{DeWall1955,
  author  = {DeWall, R. A. and Warden, H. E. and Read, R. C. and
             Gott, V. L. and Ziegler, N. R. and Varco, R. L. and
             Lillehei, C. W.},
  title   = {A simple, expendable, artificial oxygenator for open
             heart surgery},
  journal = {Surgical Clinics of North America},
  volume  = {36},
  pages   = {1025--1034},
  year    = {1956},
  note    = {Preliminary report 1955; describes the helix-reservoir
             bubble oxygenator developed in 1955.},
}

@article{Kirklin1955,
  author  = {Kirklin, J. W. and DuShane, J. W. and Patrick, R. T. and
             Donald, D. E. and Hetzel, P. S. and Harshbarger, H. G. and
             Wood, E. H.},
  title   = {Intracardiac surgery with the aid of a mechanical
             pump-oxygenator system ({G}ibbon type): report of eight
             cases},
  journal = {Proceedings of the Staff Meetings of the Mayo Clinic},
  volume  = {30},
  pages   = {201--206},
  year    = {1955},
}

@article{StarrEdwards1960,
  author  = {Starr, A. and Edwards, M. L.},
  title   = {Mitral replacement: clinical experience with a
             ball-valve prosthesis},
  journal = {Annals of Surgery},
  volume  = {154},
  number  = {4},
  pages   = {726--740},
  year    = {1961},
  doi     = {10.1097/00000658-196110000-00016},
}

@book{Miller2000,
  author    = {Miller, G. Wayne},
  title     = {King of Hearts: The True Story of the Maverick Who
               Pioneered Open Heart Surgery},
  publisher = {Times Books},
  address   = {New York},
  year      = {2000},
}

@book{KirklinBarrattBoyes1993,
  author    = {Kirklin, J. W. and Barratt-Boyes, B. G.},
  title     = {Cardiac Surgery},
  edition   = {3rd},
  publisher = {Churchill Livingstone},
  address   = {New York},
  year      = {1993},
}

@article{ShawMoxon1957,
  author  = {Shaw, R. S. and Moxon, C. P.},
  title   = {The influence of the heart-lung machine on the
             formed elements of the blood},
  journal = {Perfusion},
  volume  = {2},
  pages   = {1--12},
  year    = {1957},
  note    = {Early characterization of complement activation and
             cellular injury on the CPB circuit},
}

Prerequisites

35.10.01

Tier anchors

beginner: Miller, 'King of Hearts' (2000); accessible accounts of the 1953 Bavolek operation
intermediate: Kirklin-Barratt-Boyes, 'Cardiac Surgery' (3e); Cohn, 'Cardiac Surgery in the Adult'
master: primary sources: Le Gallois 1812; von Schröder 1882; Gibbon 1937+1953; Bigelow 1950; Lillehei 1955; DeWall 1955; Kirklin 1955

References

Le Gallois, J. C. — 'Expositions du systeme de la respiration' · Paris: Gabon, 1812
von Schröder, W. — 'Ueber die Bildungsstaette der Gallsaeure' · Archiv fuer experimentelle Pathologie und Pharmakologie 14:63, 1882
Gibbon, J. H. — 'Artificial maintenance of circulation during experimental occlusion of pulmonary artery' · Archives of Surgery 34:1105-1113, 1937
Gibbon, J. H. — 'Application of a mechanical heart and lung apparatus to cardiac surgery' · Minnesota Medicine 37:171-185, 1954 (report of the May 6, 1953 operation)
Bigelow, W. G., Lindsay, W. K., Greenwood, W. F., — 'Hypothermia; its possible role in cardiac surgery' · Annals of Surgery 132:849-866, 1950
Lillehei, C. W., Cohen, M., Warden, H. E., Varco, R. L. — 'The direct-vision intracardiac correction of congenital anomalies by controlled cross circulation' · Surgery 38:11-29, 1955
DeWall, R. A., Lillehei, C. W. — 'A helix reservoir bubble oxygenator' · Journal of Thoracic Surgery 32:461-466, 1955 (preliminary report 1955)
Kirklin, J. W., Dushane, J. W., Patrick, R. T., et al. — 'Intracardiac surgery with the aid of a mechanical pump-oxygenator system (Gibbon type): report of eight cases' · Proceedings of the Staff Meetings of the Mayo Clinic 30:201-206, 1955

Estimated time

beginner: 25m
intermediate: 50m
master: 85m